Health Catalyst, Inc: dividend

HCATNASDAQTechnology · Services-Computer Programming, Data Processing, Etc.

Price

$1.51

November 13, 2026Market cap $111M

What Ploutos Investor adds for Health Catalyst

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 9 fiscal years, from 2017
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Health Catalyst pays no dividend

It paid no regular dividend over the last 12 months. It does return money to shareholders through buybacks: 4.50% of market cap in the latest fiscal year.

All dividend stocks

Everything it returns to shareholders

The dividend is one way. The other is buybacks, which reduce the number of shares.

Dividend yield

0.00%

Buybacks

4.50%

$45.00 a year per $1,000 of shares

The share count rose by 4.8% over the year, so more shares were issued than bought back.

Total returned

4.50%

$45.00 a year per $1,000 of shares

dividend 0%buybacks 100%

The full analysis

What do Health Catalyst's filings show?

The dividend is one part of Health Catalyst's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about HCAT's dividend

Didn't find what you were looking for?

Ask us
Does HCAT pay a dividend?

It paid no regular dividend over the last 12 months. It does return money to shareholders through buybacks: 4.50% of market cap in the latest fiscal year.

How does HCAT return money to shareholders?

Health Catalyst pays no dividend. Its buybacks in the latest fiscal year came to 4.50% of market cap.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.